(Q34214855)

31 July 2017

1 reference

title

Models of chronic myeloid leukemia (English)

1 reference

31 July 2017

main subject

chronic myeloid leukemia

0 references

1 reference

Van Etten RA

1

1 reference

31 July 2017

publication date

1 May 2001

1 reference

31 July 2017

published in

Current Oncology Reports

1 reference

31 July 2017

volume

3

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

228-237

1 reference

A bcr-v-abl oncogene induces lymphomas in transgenic mice

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11912-001-0055-Y

Hematologic disease induced in BALB/c mice by a bcr-abl retrovirus is influenced by the infection conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-001-0055-Y

Bcr-Abl with an SH3 deletion retains the ability To induce a myeloproliferative disease in mice, yet c-Abl activated by an SH3 deletion induces only lymphoid malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-001-0055-Y

Differences in oncogenic potency but not target cell specificity distinguish the two forms of the BCR/ABL oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-001-0055-Y

A model of Ph' positive chronic myeloid leukemia-blast crisis cell line growth in immunodeficient SCID mice

21 January 2018

1 reference

12 December 2020

BCR/ABL P210 and P190 cause distinct leukemia in transgenic mice.

1 reference

12 December 2020

bcr-abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice.

1 reference

12 December 2020

Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome

1 reference

12 December 2020

Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice.

1 reference

12 December 2020

Stat5a/b contribute to interleukin 7-induced B-cell precursor expansion, but abl- and bcr/abl-induced transformation are independent of stat5

1 reference

12 December 2020

Expression of p210bcr/abl by metallothionein promoter induced T-cell leukemia in transgenic mice

1 reference

12 December 2020

Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis.

1 reference

12 December 2020

High level engraftment of NOD/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase.

1 reference

12 December 2020

Acute leukaemia in bcr/abl transgenic mice

1 reference

12 December 2020

Reversibility of acute B-cell leukaemia induced by BCR-ABL1.

1 reference

12 December 2020

The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity

1 reference

12 December 2020

The Grb2 binding site is required for the induction of chronic myeloid leukemia-like disease in mice by the Bcr/Abl tyrosine kinase

1 reference

12 December 2020

Reduced oncogenicity of p190 Bcr/Abl F-actin-binding domain mutants.

1 reference

12 December 2020

Differential growth patterns in SCID mice of patient-derived chronic myelogenous leukemias

1 reference

12 December 2020

Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow

1 reference

12 December 2020

Interleukin 3 and granulocyte-macrophage colony-stimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABL.

1 reference

12 December 2020

The src homology 2 domain of Bcr/Abl is required for efficient induction of chronic myeloid leukemia-like disease in mice but not for lymphoid leukemogenesis or activation of phosphatidylinositol 3-kinase

1 reference

12 December 2020

Clonal development and karyotype evolution during leukemogenesis of BCR/ABL transgenic mice

1 reference

12 December 2020

Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia.

1 reference

12 December 2020

v-abl causes hematopoietic disease distinct from that caused by bcr-abl

1 reference

12 December 2020

Regulated expression of P210 Bcr-Abl during embryonic stem cell differentiation stimulates multipotential progenitor expansion and myeloid cell fate

1 reference

12 December 2020

Restricted oncogenicity of BCR/ABL p190 in transgenic mice

1 reference

12 December 2020

Expression of interferon consensus sequence binding protein (ICSBP) is downregulated in Bcr-Abl-induced murine chronic myelogenous leukemia-like disease, and forced coexpression of ICSBP inhibits Bcr-Abl-induced myeloproliferative disorder

1 reference

12 December 2020

Bcr/Abl associated leukemogenesis in bcr null mutant mice

1 reference

12 December 2020

Efficient transplantation of BCR-ABL-induced chronic myelogenous leukemia-like syndrome in mice

1 reference

12 December 2020

The SH3 domain contributes to BCR/ABL-dependent leukemogenesis in vivo: role in adhesion, invasion, and homing

1 reference

12 December 2020

The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype

1 reference

12 December 2020

The kinetics and extent of engraftment of chronic myelogenous leukemia cells in non-obese diabetic/severe combined immunodeficiency mice reflect the phase of the donor's disease: an in vivo model of chronic myelogenous leukemia biology.

1 reference

12 December 2020

Establishment of a reproducible model of chronic-phase chronic myeloid leukemia in NOD/SCID mice using blood-derived mononuclear or CD34+ cells

1 reference

12 December 2020

Autocrine production and action of IL-3 and granulocyte colony-stimulating factor in chronic myeloid leukemia.

1 reference

12 December 2020

Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: a novel model for chronic myelogenous leukemia

1 reference

12 December 2020

Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway.

1 reference

12 December 2020

Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL.

1 reference

12 December 2020

Acquired loss of p53 induces blastic transformation in p210(bcr/abl)-expressing hematopoietic cells: a transgenic study for blast crisis of human CML.

1 reference

12 December 2020

A BCR-ABL(p190) fusion gene made by homologous recombination causes B-cell acute lymphoblastic leukemias in chimeric mice with independence of the endogenous bcr product

1 reference

12 December 2020

A primitive hematopoietic cell is the target for the leukemic transformation in human philadelphia-positive acute lymphoblastic leukemia

1 reference

12 December 2020

Development of acute lymphoblastic leukemia and myeloproliferative disorder in transgenic mice expressing p210bcr/abl: a novel transgenic model for human Ph1-positive leukemias

1 reference

12 December 2020

The SH2 domain of bcr-Abl is not required to induce a murine myeloproliferative disease; however, SH2 signaling influences disease latency and phenotype

1 reference

12 December 2020

Humanbcr-abl gene has a lethal effect on embryogenesis

1 reference

12 December 2020

Blast crisis in a murine model of chronic myelogenous leukemia

1 reference

12 December 2020

Propagation of human blastic myeloid leukemias in the SCID mouse

1 reference

12 December 2020

Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene

1 reference

12 December 2020

Blastic transformation of p53-deficient bone marrow cells by p210bcr/abl tyrosine kinase.

1 reference

12 December 2020

The severe combined immunodeficient (SCID) mouse as a model for human myeloid leukemias

1 reference

12 December 2020

10.1007/S11912-001-0055-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1050015742

0 references

1 reference